Centralised authorisation procedure 2026

The Danish share of assignments in the European pharmaceutical collaboration

The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.

Status for 2026 up to and including 3rd quarter: Denmark was assigned 10 human rapporteur/co-rapporteur cases and 2 veterinary rapporteur/co-rapporteur cases, which is respectively 5 % and 4 % of all assigned central procedure cases in 2026.

Figure 1: Amount of assigned (co)rapporteurships in the EU in 2026 up to and including 3^rd quarter

Figure 2. Share of human Rap/Co-rap cases

Table 1: Assigned human Rapporteur/co-rapporteur cases

Figure 3. Share of veterinary Rap/Co-rap cases

Please contact Send an email for further information.